News
1 in 10 Americans Has Used GLP-1 Drugs For Weight Loss, Survey Says
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 drug for weight loss, a new survey by the RAND research group reveals. About 12% say they’ve tried GLP-1 drugs, like Ozempic, Wegovy or Zepbound, with rates of use highest among people ages 50 to 64, survey results show.
Shares of WW International Inc., the company known as WeightWatchers, pared back their early gains Monday despite better-than ...
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...
Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in.
Scientists have uncovered a way to promote weight loss and improve blood sugar control without the unpleasant side effects of ...
GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...
I f you're a FuturHealth member, you'll now have a free membership to Apple Fitness Plus as part of your program. It's Apple ...
Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback